# Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT®

> **NCT03006965** · — · COMPLETED · sponsor: **Spanish Society of Thrombosis and Haemostasis** · enrollment: 50 (actual)

## Conditions studied

- Hemophilia A
- Hemophilia
- Factor VIII Deficiency

## Interventions

- **DRUG:** octocog alfa
- **DRUG:** rurioctocog alfa pegol

## Key facts

- **NCT ID:** NCT03006965
- **Lead sponsor:** Spanish Society of Thrombosis and Haemostasis
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-11
- **Primary completion:** 2022-12-22
- **Final completion:** 2022-12-22
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-06-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03006965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03006965, "Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT®". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03006965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*